<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Development and large-scale production of human milk fat analog by fermentation of microalgae</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Claude</forename><surname>Billeaud</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Francesca</forename><surname>Giu Rida</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Société</forename><surname>Des</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Produits</forename><surname>Nestlé</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Fabiola</forename><surname>Dionisi</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Leslie</forename><surname>Couedelo</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Athanasiadis</forename><forename type="middle">D</forename><surname>Doherty</surname></persName>
						</author>
						<author role="corresp">
							<persName><forename type="first">Gates</forename><forename type="middle">D</forename><surname>Destaillats</surname></persName>
							<email>fdestaillats@checkerspot.com</email>
						</author>
						<author>
							<persName><forename type="first">Xiaoying</forename><surname>Zhou</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Xinhua</forename><surname>Zhao</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Leon</forename><surname>Parker</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Paul</forename><surname>Derkach</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Mona</forename><surname>Correa</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Veronica</forename><surname>Benites</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Roberta</forename><surname>Miller</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Dino</forename><surname>Athanasiadis</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Bryce</forename><surname>Doherty</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Gawharah</forename><surname>Alnozaili</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Jon</forename><surname>Wittenberg</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Daniel</forename><surname>Gates</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Fr</forename><surname>Éd Éric Destaillats</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Walter</forename><surname>Rakitsky</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Scott</forename><surname>Franklin</surname></persName>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="laboratory">Centre Hospitalier Universitaire de Bordeaux</orgName>
								<address>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="institution">Nestlé Research Center</orgName>
								<address>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<orgName type="department">Institut des Corps Gras</orgName>
								<address>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff3">
								<address>
									<settlement>Checkerspot, Alameda</settlement>
									<region>CA</region>
									<country key="US">United States</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Development and large-scale production of human milk fat analog by fermentation of microalgae</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="DOI">10.3389/fnut.2024.1341527</idno>
					<note type="submission">RECEIVED November ACCEPTED January PUBLISHED January</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.0" ident="GROBID" when="2024-05-25T07:17+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>human milk fat analog</term>
					<term>infant nutrition</term>
					<term>OPO</term>
					<term>sn-palmitate</term>
					<term>fermentation</term>
					<term>structured TAG</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>Development and large-scale production of human milk fat analog by fermentation of microalgae.</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p>Human milk stands as an unparalleled, complex nutrient source, renowned for its intricate structural composition and diverse biological functionalities vital for infant development. Comprising 3%-5% of lipids, these nutrients serve as the primary caloric source for newborns, representing 50%-60% of the calories, or ∼70 kcal/dl, in human milk <ref type="bibr" target="#b0">(1)</ref>. In breast milk, lipids are found as globules, predominantly composed of triacylglycerols (TAG), which represent ∼98% of the total lipids <ref type="bibr" target="#b0">(1)</ref>. Human milk TAG contains a diverse range of fatty acids, spanning from caproic acid (6:0) to nervonic acid (24:1 n-9), with oleic, palmitic, and linoleic acids being the primary components <ref type="bibr" target="#b0">(1)</ref>. Notably, the TAG in human milk exhibits distinctive and conserved structures, characterized by the presence of palmitic acid at the internal position and unsaturated fatty acids like oleic and linoleic acids at the external positions <ref type="bibr" target="#b0">(1)</ref><ref type="bibr" target="#b1">(2)</ref><ref type="bibr">(3)</ref>. The specific configuration of palmitic acid in human milk TAG is also referred to as sn-2 palmitate, and this feature is largely unaffected by maternal diet variations worldwide and bestows several metabolic advantages, including enhanced absorption of TAG containing internal palmitic acid <ref type="bibr" target="#b3">(4)</ref><ref type="bibr" target="#b4">(5)</ref><ref type="bibr" target="#b5">(6)</ref>. This trait facilitates the absorption of essential nutrients such as calcium and liposoluble micronutrients while conferring immunological and anti-inflammatory properties in infants <ref type="bibr" target="#b4">(5,</ref><ref type="bibr" target="#b6">7,</ref><ref type="bibr" target="#b7">8)</ref>.</p><p>In situations where breastfeeding is not possible due to personal preferences and physiological or other constraints, providing safe alternatives with nutritional properties mirroring those of human milk becomes the alternative of choice for parents and caregivers. Over the years, numerous strategies have been explored to develop substitutes for human milk TAG. Enzymatic processes enabling the production of TAG rich in internal palmitic acid have been extensively employed in infant formula development <ref type="bibr" target="#b8">(9)</ref>. This method, categorized as a first-generation approach, has been in use for decades to improve the nutritional properties of infant formula (10-16). First-generation substitutes typically yield infant powders containing palmitic acid residing in the internal position at levels lower than 50% in commercial infant formula <ref type="bibr" target="#b8">(9)</ref>, which is a significant deviation from ∼67.8% ± 4.7% found in human milk <ref type="bibr" target="#b15">(17)</ref>. These substantial variations in the repartition's level of palmitic acid concentration potentially hold crucial nutritional implications. Consequently, continuous research endeavors are essential to augment these developments, striving to achieve higher levels of palmitic acid at the internal level and thereby enhance the nutritional quality of infant products.</p><p>In response to this challenge, this study delves into the realm of fermentation, pioneering a groundbreaking methodology aimed at producing key TAG components of human milk, such as 1,3-dioleoyl-2-palmitoyl-glycerol (OPO). Through a meticulous review of the literature related to the complex fatty acid and TAG composition found in human milk, this research identifies a specific TAG as the target for replication. An innovative approach utilizing an oleaginous microalgae strain, which undergoes a series of modifications, including classical strain improvement techniques and the incorporation of specific genetic sequences, has been used. The resulting strain was used to produce a human milk fat analog on a large scale.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>. Strain development</head><p>Modification of wild-type Prototheca moriformis strain isolate UTEX 1533 was performed to alter the stereoisomeric structure of TAG obtained by fermentation of P. moriformis to produce TAG enriched with palmitic acid (16:0) esterified to the middle position (sn-2) on the glycerol backbone. First, P. moriformis was subjected to classical mutagenesis to increase the level of palmitic acid from 25% to 30% of the total fatty acids. The classically improved strain was then genetically modified by targeted integration of a cassette encoding a heterologous lysophosphatidic acid acyl transferase (LPAAT), which is responsible for the regioselective insertion of saturated fatty acids (e.g., palmitic acid) at the sn-2 position of TAG produced by P. moriformis.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>. Production of algae oil</head><p>Algae oil was produced by fermenting the genetically modified strain of P. moriformis essentially as described in Running <ref type="bibr" target="#b16">(18)</ref> in a 50-L-scale reactor, followed by the drying of algal biomass and subsequent mechanical and solvent extraction to recover crude oil. The latter was subsequently processed using standard edible oil refining methods, including degumming, bleaching, and deodorization.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>. Fatty acid and triacylglycerol analysis</head><p>Fatty acids are measured as their fatty acid methyl esters (FAMEs), following a direct transesterification reaction with a sulfuric acid methanol solution <ref type="bibr" target="#b17">(19)</ref>. The sample is injected on an Agilent 8890 gas chromatograph system equipped with a split/splitless inlet and flame ionization detector (Agilent Technologies, Palo Alto, CA, United States). An Agilent DB-WAX column (30 m × 0.32 mm × 0.25 µm dimensions) is used for the chromatographic separation of the FAME peaks. A FAME standard mixture purchased from Nu-Chek Prep (Nu-Chek Prep Inc., Elysian, MN, United States) is injected to establish retention times. Response factor corrections were previously determined empirically using various standard mixtures from Nu-Chek Prep. Methyl non-adecanoate (19:0) is used as an internal standard for the quantitation of individual FAMEs.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>. Determination of the sn-fatty acid profile</head><p>The fatty acid composition at the sn-2 position was determined after incubating the TAGs with porcine pancreatic lipase, as described by Christie and Han <ref type="bibr" target="#b17">(19)</ref>. The lipase reaction results in deacylation of the TAG at the sn-1(3) positions, leaving sn-2-MAGs. The sn-2-MAGs were then isolated using Agilent Bond Elut amino propyl solid phase extraction cartridges (Agilent Technologies, Palo Alto, CA, United States) and subjected to fatty acid composition analysis by gas chromatography as described earlier.</p><p>. Triacylglycerol analysis TAG profiles were determined as described previously using an Agilent 1290 Infinity II UHPLC system coupled to a 6470B triple quadrupole mass spectrometer and APCI ionization source according to the parameters described previously <ref type="bibr" target="#b21">(23)</ref>. Diacylglycerol (DAG) ion ratios, carried out as described by <ref type="bibr">Byrdwell (24)</ref>, were used to assess the relative abundance of TAG regio-isomers, and quantification was performed using a calibration curve of pure 1,3-dioleoyl-2-palmitoyl-glycerol (OPO), 1,2-dioleoyl-3-palmitoyl-glycerol (OOP), 1,2-dipalmitoyl-3-oleoyl-glycerol (PPO), and 1,3-dipalmitoyl-2-oleoyl-glycerol (POP) standards. For example, OPO (876.8 m/z) was monitored by the loss of oleic acid leading to the fragment at 577.5 m/z and the loss of palmitic acid leading to the fragment at 603.5 m/z.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>. Identification of fatty acid and TAG compositional targets to guide the development of a new functional ingredient for infant nutrition</head><p>In human milk, lipids are primarily organized as globules known as milk fat globules (MFG), comprising a core of neutral TAG isolated by the layers of polar lipids, cholesterol, and transmembrane proteins <ref type="bibr" target="#b0">(1,</ref><ref type="bibr" target="#b23">25)</ref>. TAG accounts for ∼98% of MFG and consists of fatty acids with chain lengths ranging from 6 to 24 carbons <ref type="bibr" target="#b0">(1,</ref><ref type="bibr" target="#b23">25)</ref>. The analysis of the variations of the fatty acid concentration measured as relative standard deviation percentage (RSD%; Table <ref type="table">1</ref>) in a dataset comprising more than 800 samples <ref type="bibr" target="#b18">(20)</ref><ref type="bibr" target="#b19">(21)</ref><ref type="bibr" target="#b20">(22)</ref> reveals minimal variations (RSD&lt;10%) in palmitic (16:0) and stearic (18:0) acids, supporting the hypothesis that these saturated fatty acids primarily originate from an endogenous pool generated through de novo synthesis. Oleic (18:1 n-9), γ-linolenic (18:3 n-6), and arachidonic (20:4 n-6) acids exhibit intermediate variation (&lt; 15%), indicating their relative insensitivity to ethnic and dietary differences. Conversely, medium-chain fatty acids like lauric (12:0) and myristic (14:0) acids, prevalent in certain tropical fats consumed significantly in the Philippines and Indonesia, have high coefficients of variation (&gt;35%), as do linoleic (18:2 n-6) and γ-linolenic (18:3 n-3) acids, which are most abundant polyunsaturated fatty acids in vegetable oils, with coefficients of variation around 30%. Consistent with previous studies <ref type="bibr" target="#b24">(26)</ref>, concentrations of omega-3 long-chain polyunsaturated fatty acids, especially eicosapentaenoic (20:5 n-3) and docosahexaenoic (22:6 n-3) acids, vary considerably (coefficients of variation &gt;50%) due to diverse marine product consumption patterns influenced by geographical origin and dietary habits of the studied populations (Table <ref type="table">1</ref>).</p><p>The examination of TAG molecular distribution, particularly the specific arrangement of fatty acids in internal (sn-2) or external [sn-1(3)] positions, revealed distinct asymmetry for palmitic, oleic, and linoleic acids, a characteristic observed not only in human milk but also in other mammals as reported decades ago <ref type="bibr" target="#b1">(2,</ref><ref type="bibr">3,</ref><ref type="bibr">27)</ref>. Advanced mass-spectrometry techniques have identified ∼300 individual TAG species (Table <ref type="table">2</ref>), with the prominent  ones being 1,3-dioleoyl-2-palmitoyl-glycerol (OPO) &gt; 1-oleoyl-2palmitoyl-3-linoleoyl-glycerol (OPL) &gt; 1,2-dipalmitoyl-3-oleoylglycerol (PPO) &gt; 1-oleoyl-2-palmitoyl-3-stearoyl-glycerol (OPS). Studies indicate regional differences, such as in China, where high vegetable oil consumption leads to elevated linoleic acid levels in human milk, resulting in higher concentrations of OPL compared to OPO <ref type="bibr" target="#b23">(25,</ref><ref type="bibr" target="#b25">28,</ref><ref type="bibr" target="#b26">29)</ref>. In all instances, palmitic acid is consistently esterified to the sn-2 position of TAG, constituting an average of 67.8 ± 4.7% of the total palmitic acid (Table <ref type="table">3</ref>), as determined through recent high-resolution mass spectrometry methods <ref type="bibr" target="#b15">(17,</ref><ref type="bibr" target="#b23">25,</ref><ref type="bibr" target="#b25">28,</ref><ref type="bibr" target="#b26">29)</ref>.</p><p>Using the literature data presented in Tables <ref type="table">1</ref><ref type="table">2</ref><ref type="table">3</ref>, it is possible to establish compositional targets for the key fatty acids and the main TAG structures to guide the development of a new functional ingredient for infant nutrition. It is important to note that it is assumed that this ingredient's composition should emulate the structural complexity of TAG in breast milk when combined with other types of oils and fats to formulate a regulatory-compliant infant formula. Designing a strain capable of producing all the acids and TAG found in breast milk seems exceedingly challenging. Therefore, the concentration of the palmitic acid set is higher compared to human milk data to account for the effect of the dilution with other vegetable oils that might be used in the final oil mix. We assumed that the new ingredient might represent 40-60% of the total lipid composition of infant formula and used the following targets for strain development:</p><p>-OPO: 40 ± 3% of total TAG in accordance with literature data (Table <ref type="table">2</ref>).</p><p>-Palmitic acid: 30 ± 3% of total fatty acids, of which 67.8 ± 4.7% in the internal position of TAG in accordance with literature data (Table <ref type="table">3</ref>).</p><p>Due to significant fluctuations in the levels of polyunsaturated fatty acids, which are regulated differently in infant formula across countries, there are no fixed targets in place. We assumed that easily accessible sources like canola, soybean, DHA, and ARA microbial oils could be utilized to create a nutritionally complete and regulation-compliant oil mixture.</p><p>. Development of the strain and production of the algae oil A wild-type P. moriformis isolate (UTEX 1533) was mutagenized utilizing classical strain improvement to increase levels of palmitate beyond the 25% normally seen in this strain. The resulting mutant strain (named the high-palmitic acid strain) was capable of reproducibly elaborating over 30% palmitate, as shown in Table <ref type="table">4</ref>. However, regiospecific lipase treatment, followed by FAME analysis of the resulting monoacylglycerols, showed only modest changes in fatty acid distribution along the glycerol backbone. This was in contrast to the oil produced by the strain subsequent to the introduction of the heterologous LPAAT. While palmitate levels remained relatively constant between the classically improved isolate and the transgenic strain, regiospecific insertion of saturates shifted dramatically, with sn-2 levels of palmitate increasing from 6% to 69.3% in the transgenic line. Not surprisingly, sn1-3 insertion of palmitate decreased over 10-fold in the transgenic line, dropping from 35% to 3.3%. The 50-L-scale fermentation trial conclusively demonstrated the strain's capacity for oil production, achieving a yield of over 150 g of oil per liter of fermentation broth within 5 days. This outcome underscores the strain's efficiency and establishes the feasibility of upscaling the process.</p><p>Table <ref type="table">5</ref> illustrates the TAG profile of the resulting engineered strain vs. oils found in several commercially available OPO ingredients. sn-2 analysis shows that oil from the engineered microalgal strain has higher sn-2 palmitate levels than any of the commercial infant fat formulations tested (73.3% vs. 38.95% in the commercial fat containing the lowest level of palmitate at the sn-2 position). Similarly, regiospecific OPO levels in oil derived from the transgenic strain were higher than any of the commercial oils, at 38.3% vs. 21.7% in the commercial fat containing the lowest level of OPO. While levels of highly desirable OPO were higher in oil derived from the transgenic line, levels of less desirable TAG species, including OOP, PPO, and PPP, were lower in algae oil compared to any of the commercial OPO ingredient samples tested (Table <ref type="table">5</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p>The design of infant formula presents a challenge in mimicking the composition and functional properties of human milk TAG. Understanding the structure-function relationships of human milk TAG is essential for formulating nutritionally optimized infant formulas that closely mimic the benefits of human milk <ref type="bibr" target="#b23">(25)</ref>.</p><p>TABLE Fatty acid profiles of total triacylglycerols (TAG) as well as sn-( ) and sn-positions from the parent P. moriformis microalgae strain, the high palmitic acid strain generated by mutagenesis, and the OPO strain engineered by insertion of the LPAAT gene.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Parent strain</head><p>High-palmitic acid strain OPO-engineered strain  O, P, S, L, M, Ln, and G stand for oleic, palmitic, stearic, linoleic, myristic, a-linolenic, and gondoic acids, respectively. The prefix sn-indicates that the TAG species reported has a defined structure and is not a mixture of isomers.</p><p>Various strategies have been explored to incorporate human milkmimicking TAG structures into infant formulas, including lipid blending, interesterification, and structured lipid synthesis <ref type="bibr" target="#b23">(25)</ref>.</p><p>In recent years, considerable research efforts have focused on unraveling the complexities of human milk TAG and elucidating their impact on infant nutrition and health <ref type="bibr" target="#b23">(25)</ref>. Havlicekova et al. <ref type="bibr" target="#b4">(5)</ref> as well as <ref type="bibr">Miles and Calder (8)</ref> summarized in a very comprehensive review all the health benefits that emerged from investigating in animals and premature as well as term-born infants the effects of higher sn-2 palmitate content in supplemental milk formula (Figure <ref type="figure">1</ref>). The positional distribution of fatty acids within TAG is known to influence their digestion, absorption, and subsequent utilization by infants. The presence of palmitic acid at the sn-2 position (sn-2 palmitate) enhances the formation of stable emulsions during digestion, facilitating efficient lipid absorption. sn-2 palmitate improved fatty acid absorption and reduced the formation of insoluble calcium dipalmitate, leading to softer stools without increased volume <ref type="bibr" target="#b3">(4,</ref><ref type="bibr" target="#b10">(12)</ref><ref type="bibr" target="#b11">(13)</ref><ref type="bibr" target="#b12">(14)</ref><ref type="bibr" target="#b13">(15)</ref><ref type="bibr" target="#b27">(30)</ref><ref type="bibr" target="#b28">(31)</ref><ref type="bibr" target="#b29">(32)</ref><ref type="bibr" target="#b30">(33)</ref><ref type="bibr" target="#b31">(34)</ref><ref type="bibr" target="#b32">(35)</ref>. Studies also revealed a direct relationship between sn-2 palmitate content and calcium absorption, reducing calcium waste in stools and improving overall mineral balance <ref type="bibr" target="#b6">(7,</ref><ref type="bibr">(36)</ref><ref type="bibr">(37)</ref><ref type="bibr" target="#b34">(38)</ref>. Infants fed high sn-2 palmitate formula displayed significantly higher bone mineral mass compared to those fed standard formula, akin to breast-fed infants <ref type="bibr" target="#b11">(13,</ref><ref type="bibr" target="#b35">39,</ref><ref type="bibr" target="#b36">40)</ref>. While studies indicated a positive impact on bone health, further research is needed to assess long-term effects. Some studies suggest that infants fed formula enriched with sn-2 palmitate experienced reduced crying episodes and duration, especially during evenings and nights (10, <ref type="bibr" target="#b37">[41]</ref><ref type="bibr" target="#b38">[42]</ref><ref type="bibr" target="#b39">[43]</ref>. This effect may be partially attributed to a synergetic interplay between sn-2 palmitate, prebiotic oligosaccharides, and whey hydrolysate that have been used in combinations in these studies <ref type="bibr" target="#b37">(41)</ref>. sn-2 palmitate influenced the intestinal microbiome positively, increasing beneficial bacteria such as Lactobacillus and Bifidobacteria in vitro <ref type="bibr" target="#b23">(25,</ref><ref type="bibr" target="#b40">(44)</ref><ref type="bibr" target="#b41">(45)</ref><ref type="bibr" target="#b42">(46)</ref><ref type="bibr" target="#b43">(47)</ref> and in vivo settings <ref type="bibr" target="#b14">(16,</ref><ref type="bibr" target="#b30">33,</ref><ref type="bibr" target="#b44">48,</ref><ref type="bibr" target="#b45">49)</ref>. This modulation of the microbiome had immunomodulatory effects and positively influenced intestinal maturation, counteracting the growth of pathogenic bacteria <ref type="bibr" target="#b40">(44,</ref><ref type="bibr" target="#b46">(50)</ref><ref type="bibr" target="#b47">(51)</ref><ref type="bibr" target="#b48">(52)</ref><ref type="bibr" target="#b49">(53)</ref>. Experimental studies demonstrated that sn-2 palmitate might have a protective effect against intestinal inflammation <ref type="bibr" target="#b23">(25,</ref><ref type="bibr" target="#b50">54)</ref>. Animal models showed reduced intestinal erosion and other morphological changes in mice fed a high sn-2 palmitate formula, suggesting potential anti-inflammatory properties <ref type="bibr" target="#b50">(54)</ref>. Further research is necessary to fully explore the long-term impact of this aspect.</p><p>All these studies were conducted using human milk fat substitutes produced enzymatically using vegetable oils, particularly palm oil fractions, as sources of oleic and palmitic acids <ref type="bibr" target="#b8">(9)</ref>. This method was historically developed by Bungee Loders Crocklaan and Enzymotec and has been scaled up to produce various formulations under commercial names such as Betapol TM and Infat TM . With this approach, it is possible to obtain oils with palmitic acid content in the sn-2 position ranging from 39% to 65% of the total palmitic acid content [(25), <ref type="bibr">Table 5</ref>]. These concentrated oils are subsequently used as blends in combination with other oils such as coconut oil, high-oleic sunflower oil, and canola oil to achieve a nutritionally balanced composition in compliance with relevant regulations. The emergence of these sn-2 palmitate concentrates has enabled a deeper understanding of their nutritional effects and has contributed to advancements in our comprehension of the relationship between the complex TAG structures in human breast milk and their nutritional functions. Nonetheless, significant differences exist in nutritionally relevant clinical endpoints, such as fatty acid absorption, residual calcium in feces, and stool consistency, when comparing infant formulas containing these first-generation and breast-fed infants <ref type="bibr">(4, 12-15, 31, 33, 36)</ref>. Human milk fat substitutes produced by enzymatic methods contain significant levels of TAG, such as 1,3-dipalmitoyl-2-oleoyl-glycerol (POP), 1,2-dipalmitoyl-3-oleoyl-glycerol (PPO), 1,2-dipalmitoyl-2-linoleoyl-glycerol (PPL), 1-palmitoyl-2-oleoyl-3-stearoyl-glycerol (POS), and tripalmitin (PPP, Table <ref type="table">5</ref>), which are not present in such levels in breast milk (Table <ref type="table">2</ref>). The digestion of these TAGs, upon hydrolysis by various lipases active in newborns, results in the release of palmitic acid in the digestive tract <ref type="bibr" target="#b23">(25)</ref>. These free fatty acids can combine with divalent minerals, such as calcium, to form insoluble calcium dipalmitate that is excreted in feces <ref type="bibr" target="#b23">(25)</ref>.</p><p>To address the challenge of residual palmitic acid accumulation in the external position of TAG and the desire to achieve a high sn-2 palmitate content, it is crucial to minimize the use of palmitic-rich fractions derived from tropical fats for enzymatic human milk fat substitute synthesis. Instead, we explore an innovative approach by leveraging the potential of oleaginous microalgae. Although microalgae present a promising avenue for the controlled production of TAG oils, a significant challenge in developing a viable substitute for human milk fat lies in the inherent composition of TAG produced by microalgae as well as the low lipid productivity of these microorganisms <ref type="bibr" target="#b51">(55)</ref>. Unlike human breast milk and certain animal fats, microalgae and higher plants typically synthesize TAG with unsaturated fatty acids in the internal position and saturated fatty acids in the external position. To address this disparity, our research initially focused on enhancing the palmitate content, which was originally 25.3% in the parent strain (Table <ref type="table">4</ref>). Utilizing classical strain improvement techniques, we successfully increased it to slightly over 30% (Table <ref type="table">4</ref>). Subsequently, genetic transformations were employed to modify the esterification selectivity of saturated fatty acids on the glycerol backbone, favoring the production of TAG where palmitic acid predominantly occupied the internal position. This strategic approach led to the isolation of a strain consistently producing oil with a high palmitic acid concentration, reaching 69.3% (Table <ref type="table">4</ref>), esterified to the internal position. When normalizing the palmitic acid concentration in the sn-2 position to the total concentration of palmitic acid in the TAG, we achieved a level of 73.3% (Table <ref type="table">5</ref>). Notably, the primary TAG in this oil was identified as OPO, constituting ∼38.3% of the total TAG produced, as illustrated in Table <ref type="table">5</ref>.</p><p>Microalgae species like P. moriformis, used in the present study, exhibit a doubling time compared to that of yeast (around 3-4 h) when cultivated in a defined medium containing suitable sugars and the same macro-and micronutrients used by terrestrial plants. When nitrogen becomes scarce in the presence of sugars, oleaginous microalgae halt their division and transition their metabolism toward oil production, as illustrated in Figure <ref type="figure" target="#fig_1">2A</ref>. This process involves the conversion of carbon from sugars into fatty acids within the plastid, followed by their incorporation into TAG within the endoplasmic reticulum. These TAG accumulate within the cell in the form of large vesicles, leading to biomass, where ∼80% of the dry cell weight consists of oil, as depicted in Figure <ref type="figure">2B</ref>. Furthermore, this oil contains various micronutrients such as tocopherols, tocotrienols, and sterols, the composition of which varies based on the strain. Industrial-level oil production from microalgae involves specific fermentation conditions spanning 3-5 days (Figure <ref type="figure" target="#fig_1">2A</ref>). After this period, the fermentation broth is harvested and dried to obtain biomass, from which oil can be extracted using conventional pressing or solvent extraction methods. The resulting crude oil is then refined using standard techniques to yield a neutral-tasting and neutral-colored oil suitable for the formulation of nutritional products. It is imperative to emphasize that microalgae oils are cultivated under controlled fermentation conditions, allowing for a highly traceable supply chain designed to minimize exposure to chemical, microbial, and allergenic contaminants that could pose adverse health effects. A comprehensive food safety evaluation will be essential before introducing this new ingredient to the market, ensuring compliance with regulatory approvals in various legislations.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusion</head><p>The structural variations observed in TAG within human milk hold profound implications for infant health and development, particularly impacting processes like digestion, absorption, modulation of gut microbiota, immune function, and potentially long-term health outcomes. To emulate these structure-function relationships in human milk TAG, infant formulas aim to deliver optimal nutrition and promote the overall wellbeing of infants who are not exclusively breastfed. The utilization of fermentation technology signifies a significant stride in the pursuit of creating nutritionally relevant and structurally analogous analogs for human milk fat. We demonstrated that this technology enables the precise targeting of specific TAG structures, such as OPO, while minimizing the presence of TAG species like PPO, POP, POS, and PPP, which produce calcium dipalmitate, an anti-nutritional compound that hinders the optimal utilization of fatty acids and minerals in infants.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>FIGURE</head><label></label><figDesc>FIGUREHealth benefits associated with the occurrence of palmitic acid esterified in the internal position of TAG (sn-palmitate) in breast milk and infant formula (adapted from references and ).</figDesc><graphic coords="6,127.64,96.11,340.08,166.32" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>FIGURE( A )</head><label>A</label><figDesc>FIGURE(A) Schematic representation of oil production kinetics in heterotrophic microalgae Prototheca moriformis. Microalgal cells stained with BODIPY TM / ( , -Difluoro-, , , , -Pentamethyl--Bora-a, a-Diaza-s-Indacene) and imaged under fluorescence show increasing oil accumulation in response to nitrogen deprivation in a time-dependent manner. This process is reversible, and if nitrogen is returned to the system, algae will catabolize their lipid stores and re-enter a state of vegetative reproduction. (B) Micrograph of microalgae P. moriformis at the end of fermentation, displaying intracellular large oil vesicles.</figDesc><graphic coords="7,127.64,96.23,340.08,469.20" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head></head><label></label><figDesc>S, and L stand for oleic, palmitic, stearic, and linoleic acids, respectively. The prefix snindicates that the TAG species reported has a defined structure and is not a mixture of isomers. Normalized to the sum of sn-OPO, sn-OPL, sn-PPO, sn-OPS, and sn-POO as % of total TAG. Around 300 additional species have been reported in low numbers in this study. The normalized average has been estimated using the values for sn-OPO, sn-OPL, sn-OPP, sn-OPS, and sn-POO and used as indicative targets to guide the development of the new algae-derived human milk fat substitutes.</figDesc><table><row><cell cols="5">TABLE Main triacylglycerol (TAG) individual species determined by</cell></row><row><cell cols="4">high-resolution mass-spectrometry techniques on</cell><cell>human milk</cell></row><row><cell>samples ( ).</cell><cell></cell><cell></cell><cell></cell></row><row><cell>TAG</cell><cell>Average</cell><cell>SD</cell><cell cols="2">Norm. Average</cell></row><row><cell></cell><cell>(% of total TAG)</cell><cell></cell><cell cols="2">(% of main TAG  *  )</cell></row><row><cell>sn-OPO</cell><cell>13.9</cell><cell>2.1</cell><cell></cell><cell>41.2</cell></row><row><cell>sn-OPL</cell><cell>6.0</cell><cell>1.5</cell><cell></cell><cell>17.8</cell></row><row><cell>sn-PPO</cell><cell>5.7</cell><cell>1.6</cell><cell></cell><cell>16.9</cell></row><row><cell>sn-OPS</cell><cell>5.2</cell><cell>1.4</cell><cell></cell><cell>15.4</cell></row><row><cell>sn-POO</cell><cell>2.9</cell><cell>1.0</cell><cell></cell><cell>8.6</cell></row><row><cell>O, P,</cell><cell></cell><cell></cell><cell></cell></row></table><note><p>*  </p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>TABLE The</head><label>The</label><figDesc></figDesc><table><row><cell></cell><cell cols="5">level of palmitic acid esterified in the internal (sn-) and</cell></row><row><cell cols="6">external [sn-( )] positions of the triacylglycerols (TAG) expressed as</cell></row><row><cell>g/</cell><cell cols="5">g of total palmitic acid determined by high-resolution</cell></row><row><cell cols="3">mass-spectrometry techniques on</cell><cell cols="3">human milk samples ( ).</cell></row><row><cell cols="2">Palmitic acid</cell><cell cols="4">Average SD Min Max</cell></row><row><cell cols="2">sn-2 position</cell><cell></cell><cell>67.8</cell><cell>4.7</cell><cell>60.8</cell><cell>76.7</cell></row><row><cell cols="2">sn-1(3) position</cell><cell></cell><cell>32.2</cell><cell>4.7</cell><cell>23.3</cell><cell>39.2</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head></head><label></label><figDesc>When expressed in g/100 g of total palmitic acid, the level of palmitic acid esterified in the internal (sn-2) position is 73.3%. Data are expressed in g/100 g of total fatty acids.</figDesc><table><row><cell>Fatty acid</cell><cell>TAG</cell><cell>sn-( )</cell><cell>sn-</cell><cell>TAG</cell><cell>sn-( )</cell><cell>sn-</cell><cell>TAG</cell><cell>sn-( )</cell><cell>sn-</cell></row><row><cell>16:0</cell><cell>25.3</cell><cell>36.5</cell><cell>3</cell><cell>30.3</cell><cell>35</cell><cell>6</cell><cell>31.5</cell><cell>3.3</cell><cell>69.3  *</cell></row><row><cell>18:0</cell><cell>3.3</cell><cell>4.7</cell><cell>0.5</cell><cell>2.3</cell><cell>4.7</cell><cell>0.5</cell><cell>2.6</cell><cell>4.7</cell><cell>0.5</cell></row><row><cell>18:1 n-9</cell><cell>61.1</cell><cell>48.9</cell><cell>85.6</cell><cell>57.4</cell><cell>50.8</cell><cell>81.6</cell><cell>55.2</cell><cell>80.3</cell><cell>22.8</cell></row><row><cell>18:2 n-6</cell><cell>6.9</cell><cell>6.1</cell><cell>8.4</cell><cell>6.3</cell><cell>6</cell><cell>8.5</cell><cell>6.3</cell><cell>8.4</cell><cell>3.7</cell></row><row><cell>Other FA</cell><cell>3.4</cell><cell>3.9</cell><cell>2.5</cell><cell>3.8</cell><cell>3.5</cell><cell>3.3</cell><cell>4.4</cell><cell>3.3</cell><cell>3.7</cell></row><row><cell>*</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>TABLE Total</head><label>Total</label><figDesc></figDesc><table><row><cell></cell><cell cols="4">sn-palmitate and main triacylglycerols (TAG) of individual</cell></row><row><cell cols="5">species of the algae-derived human milk fat substitute developed in the</cell></row><row><cell cols="5">present study (OPO-engineered strain) and in commercial human milk fat</cell></row><row><cell cols="4">substitute samples (CS -). TAG results are expressed in g/</cell><cell>g of TAG</cell></row><row><cell cols="2">and sn-and sn-( ) palmitate data in g/</cell><cell cols="3">g of total palmitic acid.</cell></row><row><cell>TAG</cell><cell>OPO-strain engineered</cell><cell>CS</cell><cell>CS</cell><cell>CS</cell></row><row><cell>sn-2 palmitate</cell><cell>73.30</cell><cell>65.44</cell><cell>55.93</cell><cell>38.95</cell></row><row><cell>sn-1(3)</cell><cell>26.70</cell><cell>34.56</cell><cell>44.07</cell><cell>61.05</cell></row><row><cell>palmitate</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>sn-OPO</cell><cell>38.30</cell><cell>34.40</cell><cell>30.20</cell><cell>21.70</cell></row><row><cell>sn-OOP</cell><cell>2.40</cell><cell>3.30</cell><cell>4.70</cell><cell>5.90</cell></row><row><cell>sn-PPO</cell><cell>10.90</cell><cell>14.60</cell><cell>13.30</cell><cell>20.30</cell></row><row><cell>sn-POP</cell><cell>0.40</cell><cell>0.00</cell><cell>1.00</cell><cell>3.00</cell></row><row><cell>OOO</cell><cell>13.17</cell><cell>9.67</cell><cell>11.10</cell><cell>11.02</cell></row><row><cell>OPL</cell><cell>9.56</cell><cell>13.21</cell><cell>12.89</cell><cell>8.14</cell></row><row><cell>POS</cell><cell>3.91</cell><cell>5.88</cell><cell>4.81</cell><cell>6.44</cell></row><row><cell>OOM</cell><cell>2.66</cell><cell>0.00</cell><cell>0.00</cell><cell>0.42</cell></row><row><cell>OOL</cell><cell>4.88</cell><cell>4.81</cell><cell>6.23</cell><cell>3.28</cell></row><row><cell>MOP</cell><cell>2.14</cell><cell>0.00</cell><cell>0.00</cell><cell>0.00</cell></row><row><cell>LOL</cell><cell>1.31</cell><cell>0.92</cell><cell>1.47</cell><cell>0.69</cell></row><row><cell>MOL + POLn</cell><cell>1.22</cell><cell>0.00</cell><cell>0.00</cell><cell>0.00</cell></row><row><cell>OOS + POG</cell><cell>1.52</cell><cell>2.83</cell><cell>2.88</cell><cell>2.85</cell></row><row><cell>PPL</cell><cell>1.22</cell><cell>2.42</cell><cell>2.80</cell><cell>2.99</cell></row><row><cell>PPP</cell><cell>0.00</cell><cell>1.57</cell><cell>1.27</cell><cell>5.30</cell></row><row><cell>Other species</cell><cell>4.30</cell><cell>4.32</cell><cell>4.18</cell><cell>5.65</cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_0"><p>Frontiers in Nutrition frontiersin.org</p></note>
		</body>
		<back>

			<div type="funding">
<div><head>Funding</head><p>The author(s) declare financial support was received for the research, authorship, and/or publication of this article. The authors were all employees of Checkerspot at the time of this work and did not receive any funds from third parties to perform this development.</p></div>
			</div>
			<div type="availability">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Data availability statement</head><p>The analytical raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Author contributions</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conflict of interest</head><p>XZho, XZha, LP, PD, MC, VB, RM, DA, BD, GA, JW, DG, FD, WR, and SF were employed by Checkerspot, Inc, Alameda, California (USA).</p><p>The authors declare that this study received funding from Checkerspot, Inc. The funder had the following involvement with the study: study design, collection, analysis, interpretation of data, the writing of this article, and the decision to submit it for publication.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Publisher's note</head><p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Lipids in human milk</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Jensen</surname></persName>
		</author>
		<idno type="DOI">10.1007/s11745-999-0477-2</idno>
	</analytic>
	<monogr>
		<title level="j">Lipids</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="1243" to="1271" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Intramolecular fatty acid distribution in the milk fat TAG of several species</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Freeman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">L</forename><surname>Jack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Smith</surname></persName>
		</author>
		<idno type="DOI">10.3168/jds.S0022-0302(65)88350-3</idno>
	</analytic>
	<monogr>
		<title level="j">J Dairy Sci</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="853" to="858" />
			<date type="published" when="1965">1965</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Molecular weight distributions of milk fat TAG from seven species</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">C</forename><surname>Breckenridge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kuksis</surname></persName>
		</author>
		<idno type="DOI">10.1016/S0022-2275(20)38904-5</idno>
	</analytic>
	<monogr>
		<title level="j">J Lipid Res</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="473" to="478" />
			<date type="published" when="1967">1967</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Evidence that palmitic acid is absorbed assn-2 monoacylglycerol from human milk by breast-fed infants</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Innis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Dyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Nelson</surname></persName>
		</author>
		<idno type="DOI">10.1007/BF02536625</idno>
	</analytic>
	<monogr>
		<title level="j">Lipids</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="541" to="545" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Beta-palmitate-a natural component of human milk in supplemental milk formulas</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Havlicekova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Jesenak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Banovcin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kuchta</surname></persName>
		</author>
		<idno type="DOI">10.1186/s12937-016-0145-1</idno>
	</analytic>
	<monogr>
		<title level="j">Nutr J</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="1" to="8" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Palm oil and beta-palmitate in infant formula: a position paper by the European society for paediatric gastroenterology, hepatology, and nutrition (ESPGHAN) committee on nutrition</title>
		<author>
			<persName><forename type="first">J</forename><surname>Bronsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Campoy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Embleton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fewtrell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">F</forename><surname>Mis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Gerasimidis</surname></persName>
		</author>
		<idno type="DOI">10.1097/MPG.0000000000002307</idno>
	</analytic>
	<monogr>
		<title level="j">J. Pediatr. Gastroenterol. Nutr</title>
		<imprint>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="page" from="742" to="760" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Review of sn-2 palmitate oil implications for infant health</title>
		<author>
			<persName><forename type="first">F</forename><surname>Bar-Yoseph</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Lifshitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Cohen</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.plefa.2013.03.002</idno>
	</analytic>
	<monogr>
		<title level="j">Prostagland Leukotr Essential Fatty Acids</title>
		<imprint>
			<biblScope unit="volume">89</biblScope>
			<biblScope unit="page" from="139" to="143" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">The influence of the position of palmitate in infant formula TAG on health outcomes</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Miles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Calder</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.nutres.2017.05.009</idno>
	</analytic>
	<monogr>
		<title level="j">Nutr Res</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="1" to="8" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">SN2-palmitate reduces fatty acid excretion in Chinese formula-fed infants</title>
		<author>
			<persName><forename type="first">W</forename><surname>Wei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jin</forename><forename type="middle">Q</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Akoh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename></persName>
		</author>
		<idno type="DOI">10.1097/MPG.0000000000000971</idno>
		<idno>doi: 10.1097/MPG.0000000000000971</idno>
	</analytic>
	<monogr>
		<title level="j">J Pediatr Gastroenterol Nutr</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">341</biblScope>
			<date type="published" when="2016">2020. 2016</date>
		</imprint>
	</monogr>
	<note>Lipase-catalyzed synthesis of sn-2 palmitate: a review. Engineering</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">The influence of dietary palmitic acid triacylglyceride position on the fatty acid, calcium and magnesium contents of at term newborn faeces</title>
		<author>
			<persName><forename type="first">A</forename><surname>López-López</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Castellote</forename><forename type="middle">-</forename><surname>Bargalló</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">I</forename><surname>Campoy-Folgoso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Rivero-Urgel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tormo-Carnicé</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Infante-Pina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename></persName>
		</author>
		<idno type="DOI">10.1016/S0378-3782(01)00210-9</idno>
	</analytic>
	<monogr>
		<title level="j">Early Hum Dev</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="page" from="83" to="94" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Stool Saponified fatty acid, behavior, growth, and stool characteristics in infants fed a high-OPO formula: a randomized, double-blind clinical trial</title>
		<author>
			<persName><forename type="first">L</forename><surname>Shen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Li</surname></persName>
		</author>
		<idno type="DOI">10.3389/fped.2021.712201</idno>
	</analytic>
	<monogr>
		<title level="j">Front Pediatr</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">712201</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Double-blind, randomized trial of a synthetic TAG in formula-fed term infants: effects on stool biochemistry, stool characteristics, and bone mineralization</title>
		<author>
			<persName><forename type="first">K</forename><surname>Kennedy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Fewtrell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Morley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Abbott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">T</forename><surname>Quinlan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Wells</surname></persName>
		</author>
		<idno type="DOI">10.1093/ajcn/70.5.920</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Clin Nutr</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="page" from="920" to="927" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Stool fatty acid soaps, stool consistency and gastrointestinal tolerance in term infants fed infant formulas containing high sn-2 palmitate with or without oligofructose: a double-blind, randomized clinical trial</title>
		<author>
			<persName><forename type="first">J</forename><surname>Nowacki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Lien</forename><forename type="middle">R</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">W</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">T</forename><surname>Yao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
		<idno type="DOI">10.1186/1475-2891-13-105</idno>
	</analytic>
	<monogr>
		<title level="j">Nutr J</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="1" to="11" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">The relationship between stool hardness and stool composition in breast-and formula-fed infants</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">T</forename><surname>Quinlan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lockton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Irwin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Lucas</surname></persName>
		</author>
		<idno type="DOI">10.1002/j.1536-4801.1995.tb11493.x</idno>
	</analytic>
	<monogr>
		<title level="j">J Pediatr Gastroenterol Nutr</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="81" to="90" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Effects of infant formula supplemented with prebiotics and OPO on infancy fecal microbiota: a pilot randomized clinical trial</title>
		<author>
			<persName><forename type="first">B</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Zheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Lv</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Zhao</surname></persName>
		</author>
		<idno type="DOI">10.3389/fcimb.2021.650407</idno>
	</analytic>
	<monogr>
		<title level="j">Front Cell Infect Microbiol</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">650407</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Quantification of 1, 3-olein-2-palmitin (OPO) and palmitic acid in sn-2 position of TAG in human milk by liquid chromatography coupled with mass spectrometry</title>
		<author>
			<persName><forename type="first">F</forename><surname>Giuffrida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Marmet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Tavazzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Fontannaz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Sauser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">Y</forename><surname>Lee</surname></persName>
		</author>
		<idno type="DOI">10.3390/molecules24010022</idno>
	</analytic>
	<monogr>
		<title level="j">Molecules</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page">22</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<monogr>
		<author>
			<persName><forename type="first">J</forename><surname>Running</surname></persName>
		</author>
		<title level="m">Process for the Production of Ascorbic Acid With Prototheca. U.S. Patent No. 5900370A</title>
		<meeting>ess for the Production of Ascorbic Acid With Prototheca. U.S. Patent No. 5900370A<address><addrLine>Washington, DC</addrLine></address></meeting>
		<imprint>
			<publisher>U.S. Patent and Trademark Office</publisher>
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<monogr>
		<title level="m" type="main">Isolation, Separation, Identification and Lipidomic Analysis</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">W</forename><surname>Christie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Han</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2010">2010</date>
			<publisher>Oily Press</publisher>
			<pubPlace>London; Bridgwater</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Human milk fatty acid composition from nine countries varies most in DHA</title>
		<author>
			<persName><forename type="first">R</forename><surname>Yuhas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Pramuk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Lien</forename><forename type="middle">El</forename></persName>
		</author>
		<idno type="DOI">10.1007/s11745-006-5040-7</idno>
	</analytic>
	<monogr>
		<title level="j">Lipids</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="851" to="858" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Dynamics of human milk nutrient composition of women from Singapore with a special focus on lipids</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Thakkar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Giuffrida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Cristina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Castro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Mukherjee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Tran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename></persName>
		</author>
		<idno type="DOI">10.1002/ajhb.22446</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Hum Biol</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="770" to="779" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Temporal changes of human breast milk lipids of Chinese mothers</title>
		<author>
			<persName><forename type="first">F</forename><surname>Giuffrida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Cruz-Hernandez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Bertschy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Fontannaz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Masserey</forename><surname>Elmelegy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Tavazzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename></persName>
		</author>
		<idno type="DOI">10.3390/nu8110715</idno>
	</analytic>
	<monogr>
		<title level="j">Nutrients</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">715</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Matching the functionality of single-cell algal oils with different molecular compositions</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">D</forename><surname>Co</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Koutchekinia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Carney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bond</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Rakitsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Marangoni</surname></persName>
		</author>
		<idno type="DOI">10.1007/s11746-013-2405-y</idno>
	</analytic>
	<monogr>
		<title level="j">J Ame Oil Chemists&apos; Soc</title>
		<imprint>
			<biblScope unit="volume">91</biblScope>
			<biblScope unit="page" from="533" to="548" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">The updated bottom up solution applied to mass spectrometry of soybean oil in a dietary supplement gelcap</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">C</forename><surname>Byrdwell</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00216-015-8590-9</idno>
	</analytic>
	<monogr>
		<title level="j">Anal Bioanal Chem</title>
		<imprint>
			<biblScope unit="volume">407</biblScope>
			<biblScope unit="page" from="5143" to="5160" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Human milk fat substitutes: past achievements and current trends</title>
		<author>
			<persName><forename type="first">W</forename><surname>Wei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jin</forename><forename type="middle">Q</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename></persName>
		</author>
		<idno type="DOI">10.1016/j.plipres.2019.02.001</idno>
	</analytic>
	<monogr>
		<title level="j">Prog Lipid Res</title>
		<imprint>
			<biblScope unit="volume">74</biblScope>
			<biblScope unit="page" from="69" to="86" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">27. Parodi PW. Positional distribution of fatty acids in TAG from milk of several species of mammals</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Brenna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Varamini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Jensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Diersen-Schade</forename><surname>Da</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Boettcher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Arterburn</surname></persName>
		</author>
		<idno type="DOI">10.1007/BF02535223</idno>
		<idno>doi: 10.1007/BF02535223</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Clin Nutr</title>
		<imprint>
			<biblScope unit="volume">85</biblScope>
			<biblScope unit="page" from="437" to="442" />
			<date type="published" when="1982">2007. 1982</date>
		</imprint>
	</monogr>
	<note>Lipids</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Evaluation of TAG composition in commercial infant formulas on the Chinese market: a comparative study based on fat source and stage</title>
		<author>
			<persName><forename type="first">C</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Wei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Zou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jin</forename><forename type="middle">Q</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename></persName>
		</author>
		<idno type="DOI">10.1016/j.foodchem.2018.01.072</idno>
	</analytic>
	<monogr>
		<title level="j">Food Chem</title>
		<imprint>
			<biblScope unit="volume">252</biblScope>
			<biblScope unit="page" from="154" to="162" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Identification and quantification of TAG in human milk fat using ultra-performance convergence chromatography and quadrupole time-of-flight mass spectrometery with supercritical carbon dioxide as a mobile phase</title>
		<author>
			<persName><forename type="first">X</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Qi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Wei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jin</forename><forename type="middle">Q</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename></persName>
		</author>
		<idno type="DOI">10.1016/j.foodchem.2018.09.150</idno>
	</analytic>
	<monogr>
		<title level="j">Food Chem</title>
		<imprint>
			<biblScope unit="volume">275</biblScope>
			<biblScope unit="page" from="712" to="720" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Formula containing randomized fats with palmitic acid (16: 0) in the 2-position increases 16: 0 in the 2-position of plasma and chylomicron TAG in formula-fed piglets to levels approaching those of piglets fed sow&apos;s milk</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Innis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Dyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Lien</forename><forename type="middle">El</forename></persName>
		</author>
		<idno type="DOI">10.1093/jn/127.7.1362</idno>
	</analytic>
	<monogr>
		<title level="j">J Nutr</title>
		<imprint>
			<biblScope unit="volume">127</biblScope>
			<biblScope unit="page" from="1362" to="1370" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Structural position and amount of palmitic acid in infant formulas: effects on fat, fatty acid, and mineral balance</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">P</forename><surname>Carnielli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">H</forename><surname>Luijendijk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Van Goudoever</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Sulkers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Boerlage</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Degenhart</surname></persName>
		</author>
		<idno type="DOI">10.1097/00005176-199612000-00007</idno>
	</analytic>
	<monogr>
		<title level="j">J Pediatr Gastroenterol Nutr</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="553" to="560" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">The clinical effect of a new infant formula in term infants with constipation: a double-blind, randomized cross-over trial</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Bongers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>De Lorijn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Reitsma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Groeneweg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Taminiau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Benninga</surname></persName>
		</author>
		<idno type="DOI">10.1186/1475-2891-6-8</idno>
	</analytic>
	<monogr>
		<title level="j">Nutr J</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="1" to="7" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Effects of term infant formulas containing high sn-2 palmitate with and without oligofructose on stool composition, stool characteristics, and bifidogenicity</title>
		<author>
			<persName><forename type="first">M</forename><surname>Yao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Lien</forename><forename type="middle">El</forename><surname>Capeding</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Fitzgerald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ramanujam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Yuhas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename></persName>
		</author>
		<idno type="DOI">10.1097/MPG.0000000000000443</idno>
	</analytic>
	<monogr>
		<title level="j">J Pediatr Gastroenterol Nutr</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page">440</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">The effect of TAG positional distribution on fatty acid absorption in rats</title>
		<author>
			<persName><forename type="first">Lien</forename><forename type="middle">El</forename><surname>Boyle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">G</forename><surname>Yuhas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Tomarelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Quinlan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename></persName>
		</author>
		<idno type="DOI">10.1097/00005176-199708000-00007</idno>
	</analytic>
	<monogr>
		<title level="j">J Pediatr Gastroenterol Nutr</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="167" to="174" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Randomised controlled trial of a synthetic TAG milk formula for preterm infants</title>
		<author>
			<persName><forename type="first">A</forename><surname>Lucas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Quinlan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Steven</forename><surname>Abrams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ryan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Meah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Lucas</surname></persName>
		</author>
		<idno type="DOI">10.1136/fn.77.3.F178</idno>
	</analytic>
	<monogr>
		<title level="j">Arch Dis Childhood-Fetal Neonatal Edn</title>
		<imprint>
			<biblScope unit="volume">77</biblScope>
			<biblScope unit="page" from="178" to="184" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Feeding premature newborn infants palmitic acid in amounts and stereoisomeric position similar to that of human milk: effects on fat and mineral balance</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">P</forename><surname>Carnielli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">H</forename><surname>Luijendijk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Van Goudoever</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Sulkers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Boerlage</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Degenhart</surname></persName>
		</author>
		<idno type="DOI">10.4162/nrp.2008.2.1.3</idno>
		<idno>doi: 10.4162/nrp.2008.2.1.3</idno>
	</analytic>
	<monogr>
		<title level="m">F178 36</title>
		<imprint>
			<date type="published" when="1995">1995. 2008</date>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="page" from="3" to="7" />
		</imprint>
	</monogr>
	<note>Nutr Res Pract.</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Bone metabolism in cow milk allergic children</title>
		<author>
			<persName><forename type="first">L</forename><surname>Jakusova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Jesenak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Schudichova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Banovcin</surname></persName>
		</author>
		<idno type="DOI">10.1007/s13312-013-0194-x</idno>
	</analytic>
	<monogr>
		<title level="j">Indian Pediatr</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="page" from="706" to="706" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">High beta-palmitate formula and bone strength in term infants: a randomized, double-blind, controlled trial</title>
		<author>
			<persName><forename type="first">I</forename><surname>Litmanovitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Davidson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Eliakim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Regev</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Dolfin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Arnon</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00223-012-9664-8</idno>
	</analytic>
	<monogr>
		<title level="j">Calcif Tissue Int</title>
		<imprint>
			<biblScope unit="volume">92</biblScope>
			<biblScope unit="page" from="35" to="41" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Beta palmitate improves bone length and quality during catch-up growth in young rats</title>
		<author>
			<persName><forename type="first">M</forename><surname>Bar-Maisels</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Gabet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Shamir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Hiram</forename><forename type="middle">-</forename><surname>Bab</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Pasmanik-Chor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Phillip</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
		<idno type="DOI">10.3390/nu9070764</idno>
	</analytic>
	<monogr>
		<title level="j">Nutrients</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">764</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Reduction of crying episodes owing to infantile colic: a randomized controlled study on the efficacy of a new infant formula</title>
		<author>
			<persName><forename type="first">F</forename><surname>Savino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Palumeri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Castagno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Cresi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Dalmasso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Cavallo</surname></persName>
		</author>
		<idno type="DOI">10.1038/sj.ejcn.1602457</idno>
	</analytic>
	<monogr>
		<title level="j">Eur J Clin Nutr</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="1304" to="1310" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Reduced crying in term infants fed high beta-palmitate formula: a double-blind randomized clinical trial</title>
		<author>
			<persName><forename type="first">I</forename><surname>Litmanovitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bar-Yoseph</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Lifshitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Davidson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Eliakim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Regev</surname></persName>
		</author>
		<idno type="DOI">10.1186/1471-2431-14-152</idno>
	</analytic>
	<monogr>
		<title level="j">BMC Pediatr</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="1" to="6" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Reduced crying and favourable stool characteristics in Chinese infants fed milk fat-based formula</title>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">Y</forename><surname>Sheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Buthmanaban</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Vonk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Feitsma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Parikh</surname></persName>
		</author>
		<idno type="DOI">10.1155/2020/1807397</idno>
	</analytic>
	<monogr>
		<title level="j">Asia Pac J Clin Nutr</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="144" to="151" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Infant formula supplemented with 1, 3-olein-2-palmitin regulated the immunity, gut microbiota, and metabolites of mice colonized by feces from healthy infants</title>
		<author>
			<persName><forename type="first">Q</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Xie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Evivie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Cao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Wang</surname></persName>
		</author>
		<idno type="DOI">10.3168/jds.2021-21736</idno>
	</analytic>
	<monogr>
		<title level="j">J Dairy Sci</title>
		<imprint>
			<biblScope unit="volume">105</biblScope>
			<biblScope unit="page" from="6405" to="6421" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Effects of 1, 3-dioleoyl-2-palmitoylglycerol and its plantoil formula on the toddler fecal microbiota during in vitro fermentation</title>
		<author>
			<persName><forename type="first">A</forename><surname>Hou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Xiao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Li</surname></persName>
		</author>
		<idno type="DOI">10.1080/19476337.2019.1648555</idno>
	</analytic>
	<monogr>
		<title level="j">CyTA-J Food</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="850" to="863" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">The effect of calcium palmitate on bacteria associated with infant gut microbiota</title>
		<author>
			<persName><forename type="first">L</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Bravo-Ruiseco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Happe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>He</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Van Dijl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Harmsen</surname></persName>
		</author>
		<idno type="DOI">10.1002/mbo3.1187</idno>
	</analytic>
	<monogr>
		<title level="j">Microbiologyopen</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">1187</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Dose-related effects of sn-2 palmitate, a specific positional distributed human milk fatty acid, intake in early life on the composition and metabolism of the intestinal microbiota</title>
		<author>
			<persName><forename type="first">S</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Zheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Guo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Xie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Zhai</surname></persName>
		</author>
		<idno type="DOI">10.3168/jds.2023-23361</idno>
	</analytic>
	<monogr>
		<title level="j">J Dairy Sci</title>
		<imprint>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Effect of high β-palmitate content in infant formula on the intestinal microbiota of term infants</title>
		<author>
			<persName><forename type="first">S</forename><surname>Yaron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Shachar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Abramas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Riskin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Bader</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Litmanovitz</surname></persName>
		</author>
		<idno type="DOI">10.1097/MPG.0b013e31827e1ee2</idno>
	</analytic>
	<monogr>
		<title level="j">J Pediatr Gastroenterol Nutr</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="page" from="376" to="381" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Safety, growth, and support to healthy gut microbiota by an infant formula enriched with functional compounds</title>
		<author>
			<persName><forename type="first">E</forename><surname>Civardi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Garofoli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Longo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Mongini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Grenci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Mazzucchelli</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.clnu.2015.11.006</idno>
	</analytic>
	<monogr>
		<title level="j">Clin Nutr</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="238" to="245" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Environmental factors and their impact on the intestinal microbiota: a role for human disease?</title>
		<author>
			<persName><forename type="first">L</forename><surname>Biedermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Rogler</surname></persName>
		</author>
		<idno type="DOI">10.1159/000342590</idno>
	</analytic>
	<monogr>
		<title level="j">Dig Dis</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="20" to="27" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">The human gut microbiome and body metabolism: implications for obesity and diabetes</title>
		<author>
			<persName><forename type="first">S</forename><surname>Devaraj</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Hemarajata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Versalovic</surname></persName>
		</author>
		<idno type="DOI">10.1373/clinchem.2012.187617</idno>
	</analytic>
	<monogr>
		<title level="j">Clin Chem</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="617" to="628" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Effect of intestinal microbial ecology on the developing brain</title>
		<author>
			<persName><forename type="first">M</forename><surname>Douglas-Escobar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Elliott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Neu</surname></persName>
		</author>
		<idno type="DOI">10.1001/jamapediatrics.2013.497</idno>
	</analytic>
	<monogr>
		<title level="j">JAMA Pediatr</title>
		<imprint>
			<biblScope unit="volume">167</biblScope>
			<biblScope unit="page" from="374" to="379" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Breast milk lipids and fatty acids in regulating neonatal intestinal development and protecting against intestinal injury</title>
		<author>
			<persName><forename type="first">Ramiro-Cortijo D</forename><surname>Singh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Medina-Morales</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Yakah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Freedman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename></persName>
		</author>
		<idno type="DOI">10.3390/nu12020534</idno>
	</analytic>
	<monogr>
		<title level="j">Nutrients</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page">534</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">High beta-palmitate fat controls the intestinal inflammatory response and limits intestinal damage in mucin Muc2 deficient mice</title>
		<author>
			<persName><forename type="first">P</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bar-Yoseph</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Levi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Lifshitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Witte-Bouma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>De Bruijn</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0065878</idno>
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">65878</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Comparison of fatty acid composition and positional distribution of microalgae TAG for human milk fat substitutes</title>
		<author>
			<persName><forename type="first">Y</forename><surname>He</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Luo</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.algal.2018.11.004</idno>
	</analytic>
	<monogr>
		<title level="j">Algal Res</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="40" to="50" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
